Wednesday, December 31, 2025

Canada’s Politics and Government News Source Since 1989

Wednesday, December 31, 2025 | Latest Paper

Policy Topics | Policy Briefings

Biotechnology

Guillaume Couillard, director general at the Patented Medicine Prices Review Board, says that the high number of investigations in 2023 and 2024 are due to one approach set by the 2022 temporary guidelines, which will be replaced by permanent guidance on Jan. 1, 2026. Photograph courtesy of the Patented Medicine Prices Review Board

MOST RECENT POLICY BRIEFINGS

Theresa Tam
Dr. Theresa Tam was Canada’s chief public health officer between June 26, 2017, and June 20, 2025. The Hill Times photograph by Andrew Meade

Upcoming Policy briefings

See all upcoming 2022 Hill Times Policy Briefings

Exclusive lists